Inhibition of Breast Cancer Growth Using Antisense Oligonucleotides
Author Information
Author(s): Lamb Caroline A, Helguero Luisa A, Giulianelli Sebastián, Soldati Rocío, Vanzulli Silvia I, Molinolo Alfredo, Lanari Claudia
Primary Institution: Instituto de Biología y Medicina Experimental (CONICET), Buenos Aires, Argentina
Hypothesis
Can antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice?
Conclusion
The study demonstrates that antisense oligonucleotides can inhibit tumor growth in vivo, highlighting the role of the progesterone receptor pathway in mammary carcinomas.
Supporting Evidence
- Antisense oligonucleotides significantly inhibited tumor growth in treated mice.
- Histological signs of tumor regression were observed in asPR-treated mice.
- Decreased levels of phosphorylated ERK were noted in tumors treated with asPR.
Takeaway
Scientists found a way to stop some breast cancer tumors from growing by using special molecules that block a hormone's action.
Methodology
The study involved injecting mice with antisense oligonucleotides and measuring tumor growth over time.
Limitations
The study was conducted in mice, which may not fully replicate human responses.
Participant Demographics
Two-month-old virgin female BALB/c mice were used in the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website